During the past decade, Osaka Saiseikai Senri Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Osaka Saiseikai Senri Hospital" are "Anemia" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiac Arrest" (1 trials), "Chronic Kidney Disease" (1 trials) and "Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Osaka Saiseikai Senri Hospital" in a lesser frequency.

Most popular intervention types in "Osaka Saiseikai Senri Hospital" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Tirzepatide" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osaka Saiseikai Senri Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Osaka Saiseikai Senri Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Osaka Saiseikai Senri Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osaka Saiseikai Senri Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".